Sumex 1% w/v solution for injection for pigs

Country: Irlanda

Lingwa: Ingliż

Sors: HPRA (Health Products Regulatory Authority)

Ixtrih issa

Ingredjent attiv:

Ivermectin

Disponibbli minn:

Chanelle Animal Health Ltd.

Kodiċi ATC:

QP54AA01

INN (Isem Internazzjonali):

Ivermectin

Dożaġġ:

1 percent weight/volume

Għamla farmaċewtika:

Solution for injection

Tip ta 'preskrizzjoni:

LM: Licensed Merchant as defined in relevant national legislation

Grupp terapewtiku:

Pigs

Żona terapewtika:

ivermectin

Indikazzjonijiet terapewtiċi:

Endectoparasiticides

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

2002-06-28

Karatteristiċi tal-prodott

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Sumex 1% w/v solution for injection for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance
Ivermectin
1.0% w/v (10 mg/ml)
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for injection
Clear, colourless to slightly yellow solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated for the effective treatment of the following
harmful parasites of pigs:
GASTROINTESTINAL WORMS (adult and fourth stage larvae):
_Ascaris suum,_
_Hyostrongylus rubidus_,
_Oesophagostomum spp_,
_Strongyloides ransomi_ (adult and somatic larval stage)
LUNGWORMS:
_Metastrongylus spp_. (adult)
LICE:
_HAEMATOPINUS SUIS_
MANGE MITES:
_Sarcoptes scabiei_ var._ suis_
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_3_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_5_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_2_
_4_
_9_
_2_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.3 CONTRAINDICATIONS
Do not administer by the intravenous or intramuscular route.
Do not use in cases of known hypersensitivity to the active
ingredient.
Do not use in cats and dogs as severe adverse reactions may occur.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Parasite resistance to any particular
class
of
anthelmintic may develop following frequent,
repeated use of
an
anthelmintic of that c
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott